WEARING A MASK IS STILL REQUIRED TO ENTER SUNNYBROOK. VISITORS AND PATIENTS MUST ALSO BE ASYMPTOMATIC & SHOULD BE FULLY VACCINATED. »

Hospital  >  News & media  >  News
Share:  
|

Research news

 
Friday, January 27, 2023 Then and Now: Dr. Sandra Black on advancing Alzheimer’s research
A timeline of advancing Alzheimer’s research at Sunnybrook
Monday, January 23, 2023 Sunnybrook researchers awarded more than $6M in CIHR clinical trials funding
The Clinical Trials Fund is designed to enhance Canada’s clinical trials ecosystem from discovery to implementation, determining which new drugs, treatments, and therapies are safe and effective for the population.
Friday, January 20, 2023 Sunnybrook study measures the impact of expanding critical care capacity beyond the ICU
The study demonstrates the impact humidified oxygen therapy, known as high-flow nasal cannula (HFNC) oxygen therapy, had on patients and hospital resources.
Wednesday, January 18, 2023 INOVAIT invests in the Canadian image-guided therapy sector through its Focus Fund
Fund from Sunnybrook-led network will inject up to $22.7 million into the image-guided therapy sector to ultimately deliver better health care to Canadians
Friday, December 23, 2022 New Platform Director, Biological Sciences
Dr. JoAnne McLaurin is currently a senior scientist in Biological Sciences and the Hurvitz Brain Sciences Research Program at SRI and holds a Tier 1 Canada Research Chair in Alzheimer’s Disease Therapeutics.
  1 2 3 4 >